Royalties on Ribozyme Products Sample Clauses

Royalties on Ribozyme Products. Subject to the limitation of payments to be made by Schering pursuant to Section 10.4(b) and (c) during the Royalty Term, Schering shall pay to RPI a royalty of (i) [ ] on Net Sales of each Ribozyme Product ("Royalty"), provided however, if, pursuant to Sections 9.4 and 9.5, Schering is required to pay any Third Party a royalty on a Ribozyme Product or for the use of Ribozyme pursuant to this Agreement and such royalty is paid for a license because of such use or because the Ribozyme Product contains a Ribozyme or because the Ribozyme Product was made using a Ribozyme then one hundred (100%) percent of such royalty shall be deducted from the percentage Royalty paid to RPI; (ii) plus for Exogenous Ribozyme Products manufactured by RPI ("Bonus Royalty"): (a) [ ] if: (i) Annual Net Sales are less than [ ] and RPI's Transfer Price to Schering as a percentage of Net Sales is [ ] (ii) Annual Net Sales are greater than [ ] but less than [ ] and RPI's Transfer Price to Schering as a percentage of Net is Sales greater than [ ] (b) [ ] if: (i) Annual Net Sales are [ ] and RPI's Transfer Price to Schering as a percentage of Net Sales is greater than [ ] but less or equal to [ ] (ii) Annual Net Sales are greater than [ ] but less than [ ] and RPI's Transfer Price to Schering is greater than [ ] but less than, or equal to [ ] (iii) Annual Net Sales are greater than [ ] but less than [ ] and RPI's Transfer Price to Schering as a percentage of Net Sales is greater than [ ] but less than [ ] or (c) [ ] if: (i) Annual Net Sales are less than [ ] and RPI's Transfer Price as a percentage of Net Sales is less than or equal to [ ]